Could valproic acid be an effective anticancer agent? The evidence so far

le Brodie, Seth A, Brandes, Johann C
Foilsithe in Expert Rev Anticancer Ther (2014)

Molecular characteristics of non small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project

le Brodie, Seth A, Li, Ge, Brandes, Johann C
Foilsithe in Respir Med (2014)

Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications

le McCabe, Michael T., Brandes, Johann C., Vertino, Paula M.
Foilsithe 2009

Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer

le Brodie, Seth A., Li, Ge, Harvey, Donald, Khuri, Fadlo R., Vertino, Paula M., Brandes, Johann C.
Foilsithe in Oncotarget (2015)

Real-World Effectiveness of Systemic Agents Approved for Advanced Non-Small Cell Lung Cancer: A SEER–Medicare Analysis

le Owonikoko, Taofeek K., Ragin, Camille, Chen, Zhengjia, Kim, Sungjin, Behera, Madhusmita, Brandes, Johann C., Saba, Nabil F., Pentz, Rebecca, Ramalingam, Suresh S., Khuri, Fadlo R.
Foilsithe 2013

Aberrant Promoter Methylation of Caveolin-1 Is Associated with Favorable Response to Taxane-Platinum Combination Chemotherapy in Advanced NSCLC

le Brodie, Seth A., Lombardo, Courtney, Li, Ge, Kowalski, Jeanne, Gandhi, Khanjan, You, Shaojin, Khuri, Fadlo R., Marcus, Adam, Vertino, Paula M., Brandes, Johann C.
Foilsithe 2014

Enhanced Anti-tumor Activity by the Combination of the Natural Compounds (−)-Epigallocatechin-3-gallate and Luteolin: POTENTIAL ROLE OF p53

le Amin, A. R. M. Ruhul, Wang, Dongsheng, Zhang, Hongzheng, Peng, Shifang, Shin, Hyung Ju C., Brandes, Johann C., Tighiouart, Mourad, Khuri, Fadlo R., Chen, Zhuo Georgia, Shin, Dong M.
Foilsithe 2010

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

le Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Foilsithe 2013

Class I HDACs are mediators of smoke-carcinogen induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer

le Brodie, Seth A, Li, Ge, El-Kommos, Adam, Kang, Hyunseok, Ramalingam, Suresh S, Behera, Madhusmita, Gandhi, Khanjan, Kowalski, Jeanne, Sica, Gabriel L, Khuri, Fadlo R, Vertino, Paula M., Brandes, Johann C
Foilsithe 2014

CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC

le Pillai, Rathi N, Brodie, Seth A, Sica, Gabriel L, Shaojin, You, Li, Ge, Nickleach, Dana C, Yuan, Liu, Varma, Vijay A, Bonta, Dacian, Herman, James G, Brock, Malcom V, Ribeiro, Maria JA, Ramalingam, Suresh S, Owonikoko, Taofeek K, Khuri, Fadlo R, Brandes, Johann C
Foilsithe 2013

Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies

le Shin, Dong M., Zhang, Hongzheng, Saba, Nabil, Chen, Amy, Nannapaneni, Sreenivas, Amin, A.R.M. Ruhul, Müller, Susan, Lewis, Melinda, Sica, Gabriel, Kono, Scott, Brandes, Johann C., Grist, William, Moreno-Williams, Rachel, Beitler, Jonathan J., Thomas, Sufi M., Chen, Zhengjia, Shin, Hyung Ju C., Grandis, Jennifer R., Khuri, Fadlo R., Chen, Zhuo Georgia
Foilsithe 2013